IFI-M · PCS Tri-Axis Balanced Series

Specimen SS-F-M3-01174 // MULTI-AXIS · IFI-M

PCS Tri-Axis Balanced Series V-IV

Brassica nigra

Black Mustard

Tier VPCS Tri-Axis Balanced Series

Target Trait

2.5×

fold-change

Sharp+Cooling+Sweet balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01174

Genomic Edits

12

GC Content

45.4%

Construct Length

6,651 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + TRPM8 + TAS1R2/TAS1R3

IFI Score

250

Pathway Edits

  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent PCS pathway operation
  • Cross-pathway regulatory circuit for balanced PCS triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and TAS1R2/TAS1R3 pathways simultaneously engineeredBalanced tri-axis expression strategy (PCS) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier V PCS triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?